A Phase I/IIa Safety and Efficacy Study of Nebulized Liposome-mediated Gene Therapy for Cystic Fibrosis Supports a Multidose Trial.
- Submitting institution
-
University of Oxford
- Unit of assessment
- 1 - Clinical Medicine
- Output identifier
- 12777
- Type
- D - Journal article
- DOI
-
10.1164/rccm.201506-1193le
- Title of journal
- American journal of respiratory and critical care medicine
- Article number
- -
- First page
- 1389
- Volume
- 192
- Issue
- 11
- ISSN
- 1073-449X
- Open access status
- Out of scope for open access requirements
- Month of publication
- December
- Year of publication
- 2015
- URL
-
-
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
49
- Research group(s)
-
-
- Citation count
- 30
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- The author made a substantial contribution to the conception and design of the study AND to the organisation of the conduct of the study AND to carrying out the study AND to analysis and interpretation of study data. The author helped draft the output.
- Non-English
- No
- English abstract
- -
